ImmunityBio recently reported positive clinical data from its ANKTIVA (nogapendekin alfa inbakicept) program in non-small ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

Biological age tests measure how fast your body is aging compared to your actual age. These tests rely on biomarkers tied to ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C.

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

"Across the GCC there's a hunger for measurable and science-backed longevity. People want data, they want speed, and they act on it," says wellness expert Aly Rahimtoola ...

Spear Bio joins collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and ...

Elevators into space, robot roommates and bio-printed organs are among the technological developments that could become ...

The Phase 2a trial enrolled 35 IPF patients randomized in a 2:1 ratio to receive either GRI-0621 or placebo once daily for 12 weeks. A sub-study examined immune cells in bronchoalveolar lavage fluid ...

The average one-year price target for Instil Bio (NasdaqCM:TIL) has been revised to $53.55 / share. This is a decrease of 45.17% from the prior estimate of $97.66 dated December 18, 2025. The price ...